Science News
Enterovirus: CDC Investigates Colorado Children For Link Between ED-68 And Paralysis
IBTimes - 28 Sep 2014 06:34
Health researchers are investigating whether the enterovirus-68 respiratory disease that's been seen in especially high rates this year is related to a neurological condition that causes limb weakness and paralysis. In a...
Human genome was shaped by an evolutionary arms race with itself
Science Daily - 28 Sep 2014 21:47
An evolutionary arms race between rival elements within the genomes of primates drove the evolution of complex regulatory networks that orchestrate the activity of genes in every cell of our bodies, researach shows. The ...
Early sign of pancreatic cancer identified by researchers
Science Daily - 28 Sep 2014 21:47
A sign of the early development of pancreatic cancer -- an upsurge in certain amino acids that occurs before the disease is diagnosed and symptoms appear -- has been identified by a team of researchers. Although the incr...
Virtual Reality May Become the Next Great Media Platform--But Can It Fool All Five Senses?
Singularity Hub - 28 Sep 2014 19:48
Jason Silva calls technologies of media "engines of empathy." They allow us to look through someone else's eyes, experience someone else's story--and develop a sense of compassion and understanding for them, and perhaps ...
Adding cediranib to chemotherapy improves progression-free survival for metastatic or recurrent cervical cancer, phase II trial shows
Science Daily - 28 Sep 2014 18:56
For patients with cervical cancer that has recurred after treatment or has spread elsewhere in the body, adding the experimental drug cediranib to standard chemotherapy improves tumor shrinkage and adds a modest improvem...
Pertuzumab adds 16 months survival benefit to trastuzumab and chemotherapy treatment for HER2-positive metastatic breast cancer
Science Daily - 28 Sep 2014 18:56
Patients with HER2-positive breast cancer that has spread to other parts of their body live around 16 months longer if treated with a combination of pertuzumab, trastuzumab and chemotherapy compared to those treated with...